S82F (p.Ser82Phe) variant of TNXB (Tenascin-X)

S82F (p.Ser82Phe) in TNXB (Tenascin-X) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.69 / 1. The record also includes structural context.

S82F (p.Ser82Phe) variant details